Formulation Development
FORMULATION DEVELOPMENT WHITE PAPERS & ARTICLES
-
Cracking Complexity: Leveraging Lessons Learned For Future Bispecific Development
The shift from static platforms to adaptive, knowledge-driven development helps biopharma teams manage BsAb complexity, accelerate analytical, purification, and formulation development, and improve IND readiness.
-
High-Dose Delivery: Integration And Performance
High-viscosity therapies bring new delivery challenges. Explore how needle, syringe, and device design affect injection performance, reliability, and user experience.
-
Flying On Two Wings: Balancing Local Agility And Global Quality In China
As China expands its role in drug development, injectable therapy programs face new demands. Learn how manufacturers are scaling quality, devices, and production for global success.
-
Getting Breakthrough Biotechnologies To Market
Biotechnology moves quickly, and successful innovation depends on more than breakthrough science. Learn how adaptable strategies can help teams connect emerging tools and manage uncertainty.
-
Therapeutic Peptides: Challenges And Solutions For Drug Developers
Therapeutic peptide manufacturing depends on more than synthesis. Discover approaches for verifying raw materials, detecting difficult impurities, and confirming complex sequences with confidence.
FORMULATION DEVELOPMENT APPLICATIONS & STUDIES
-
Evaluating Clone Performance And Cell-Specific Productivity
See how continuous process monitoring and automated at-line analytics support confident CHO clone ranking, consistent cultivation, and scale-up by connecting pH, viable cell density, and more.
-
A Comparison To Traditional Clone Screening Platforms
See how 46 CHO clones performed across automated, deep-well, and microbioreactor fed-batch cultures, using cell density, viability, and IgG concentration to evaluate clone performance.
-
A Sensory Panel Study With The Focus On High-Intensity Sweeteners
Gain insight into the sensory performance of five high-intensity sweeteners in a simulated bitter formulation, including their effects on sweetness, bitterness, aftertaste, and covering ability.
-
Characterizing mRNA Using Ion-Pairing Reversed-Phase LC/MS
mRNA poly(A) tail analysis depends on targeted digestion, clean LC/MS conditions, and reliable deconvolution. See how RNase 4 digestion and optimized ion-pairing methods support reproducible results.
-
Effect Of Column Chemistry On The Separation Of GLP-1 Peptides
Small changes in mobile phase, temperature, and column chemistry can affect the detection of GLP-1 peptide impurities. Learn which conditions improve resolution for challenging peptide analyses.
FORMULATION DEVELOPMENT SOLUTIONS
- Capacity To Secure Your Success
- Neotame And Sucralose: Two Ways To Ace The Taste Test
- Intelligent, Precise, And Scalable Automation Solution For 3D Biology
- CDO Services: Agile. Flexible. Focused On You.
- Complete Organ-Chip Solutions To Fast-Track Your Drug Discovery
- Scaling High-Potency APIs From Consulting To Containment
- Small Molecule Discovery Network And Capabilities
- Addressing Your Requirements For Parenteral Applications
- Reliable RNA And cfDNA Results Begin With Cleaner Reagents
- Improve The Performance Of Your Biologic Formulations
PHARMACEUTICAL AND FORMULATION DEVELOPMENT NEWS
- METTLER TOLEDO Introduces LightningBuild Program For Four-Week Delivery
- Ypsomed Opens Production Site In China
- Ypsomed Launches YpsoLoop As The First Autoinjector Platform Designed For Circularity
- Ypsomed Expands Offering For Clinical Studies
- Ypsomed Receives The Red Dot Design Award 2026 For YpsoLoop
- Ypsomed Receives FDA Clearance For SmartPilot
- Project Farma Acquires SimoTech To Expand Life Sciences Manufacturing Services
- Bristol Myers Squibb Selects Houston For Major $2.3B Manufacturing Investment
- Harro Höfliger Expands European Footprint With New France Subsidiary
- ILC Dover Introduces EZJetFlo™ Technology To Transform Powder Dissolution And Mixing In Biopharmaceutical Manufacturing